Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/08/1998US5846770 DNA molecules encoding human chordin
12/08/1998US5846766 Oxytocin receptor and DNA coding therefor
12/08/1998US5846757 Human calcium channel α1, α2, and β subunits and assays using them
12/08/1998US5846755 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds
12/08/1998US5846746 Antibody to ocular and vaginal surface epithelium
12/08/1998US5846743 Polyphoshoinositide binding peptides for intracellular drug delivery
12/08/1998US5846740 Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase
12/08/1998US5846738 Synthetic standard for immunoassays
12/08/1998US5846734 Mammalian adipogenic factors
12/08/1998US5846725 Methods for identifying cisplatin resistant tumor cells
12/08/1998US5846723 Methods for detecting the RNA component of telomerase
12/08/1998US5846720 Methods of determining chemicals that modulate expression of genes associated with cardiovascular disease
12/08/1998US5846718 Identification of pyrazinamide-resistant mycobacteria and methods for treating mycobacterial infections
12/08/1998US5846715 CD46 variants
12/08/1998US5846714 Method of identifying a chemical that alters dissociation of an NF-KB/IKB complex
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846711 Nuclear hormone receptor-interacting polypeptides and related molecules and methods
12/08/1998US5846569 Colostrum supplement
12/08/1998US5846565 Controlled local delivery of chemotherapeutic agents for treating solid tumors
12/08/1998US5846548 Combined administration of mitogenic immumo stimulator and a thymomimetic
12/08/1998US5846547 Streptococcal C5a peptidase vaccine
12/08/1998US5846546 Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
12/08/1998US5846545 Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
12/08/1998US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
12/08/1998US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
12/08/1998US5846536 Restoration of normal phenotype in cancer cells
12/08/1998US5846535 Methods for reducing tumor cell growth by using antibodies with broad tumor reactivity and limited normal tissue reactivity
12/08/1998US5846534 Antibodies to the antigen campath-1
12/08/1998US5846532 Method and composition for the treatment of disorders involving immunological dysfunction
12/08/1998US5846531 Marine mela gene
12/08/1998US5846528 Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
12/08/1998US5846526 Treatment of autoimmune disorders with oral interferon
12/08/1998US5846525 Protected biopolymers for oral administration and methods of using same
12/08/1998US5846458 Inhibition adsorption of proteins on the liposome surface
12/08/1998US5846225 Gene transfer therapy delivery device and method
12/08/1998CA2108330C Enhancer for the antianemia effect of erythropoietin and method of augmenting the antianemia effect of erythropoietin
12/08/1998CA2073180C Therapeutic uses of melanin
12/08/1998CA2066612C Method of producing fusion proteins
12/08/1998CA2056086C Cloned gene encoding for bacteriocin from pediococcus acidilactici
12/08/1998CA2038935C Biologically active drug polymer derivatives and method for preparing same
12/05/1998CA2233591A1 Novel compounds
12/04/1998CA2233587A1 Novel compounds
12/03/1998WO1998054572A1 Methods for evaluating tissue morphogenesis and activity
12/03/1998WO1998054366A1 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
12/03/1998WO1998054365A1 Control of immune responses by modulating activity of glycosyltransferases
12/03/1998WO1998054347A1 Integrin-targeting vectors having transfection activity
12/03/1998WO1998054345A1 Mini-adenoviral vector
12/03/1998WO1998054344A2 Modulators of morphogen expression and methods of identifying the same
12/03/1998WO1998054333A2 Mammalian caax processing enzymes
12/03/1998WO1998054326A1 Human chemokine zchemo-8
12/03/1998WO1998054324A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998WO1998054323A1 The siva genes involved in cd27-mediated apoptosis
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998WO1998054321A1 New human dp1 homolog
12/03/1998WO1998054320A1 Human metaxin protein
12/03/1998WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054315A1 Cell growth-controlling oligonucleotides
12/03/1998WO1998054314A1 Antimicrobial peptides derived from ubiquicidine
12/03/1998WO1998054313A2 Dna methyltransferase genomic sequences and antisense oligonucleotides
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054302A2 Human lysophosphatidic acid acyltransferase
12/03/1998WO1998054301A2 Transplants for myocardial scars and method and cellular preparations therefor
12/03/1998WO1998054299A1 A TUMOR SUPPRESSOR PATHWAY IN $i(C. ELEGANS)
12/03/1998WO1998054298A1 Overexpression of cardiac receptors for myocardial protection
12/03/1998WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
12/03/1998WO1998054222A1 Cyclic crf agonists
12/03/1998WO1998054221A1 Cyclic crf antagonist peptides
12/03/1998WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
12/03/1998WO1998054217A1 Angiostatin fragments and method of use
12/03/1998WO1998054216A1 Gene and amino acid sequences for novel transcription factor
12/03/1998WO1998054213A2 Neurotrophic factor receptors
12/03/1998WO1998054212A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor
12/03/1998WO1998054211A2 Cyclodepsipeptides and pharmaceutical compositions containing them
12/03/1998WO1998054210A1 Peptide compositions for tumor inhibition
12/03/1998WO1998054209A2 Human mast cell function-associated antigen (mafa) and uses thereof
12/03/1998WO1998054208A1 CONFORMATIONALLY CONSTRAINED PEPTIDOMIMETICS AS β-TURN TEMPLATES AND MODULATORS OF SH3 DOMAINS
12/03/1998WO1998054207A1 Anti-inflammatory tyrosine derivatives
12/03/1998WO1998054206A1 32 human secreted proteins
12/03/1998WO1998054205A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
12/03/1998WO1998054203A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies
12/03/1998WO1998054202A1 Human tumor necrosis factor receptor tr10
12/03/1998WO1998054201A1 Human tumor necrosis factor receptor-like protein 8
12/03/1998WO1998054200A1 Cloning and uses of bcl-8
12/03/1998WO1998054199A1 Tissue plasminogen activator-like protease
12/03/1998WO1998054123A1 Substituted peptidylamine calcium channel blockers
12/03/1998WO1998053853A1 Combined product associating a nucleic acid with a substance breaking up the extracellular matrix for gene therapy
12/03/1998WO1998053850A2 Compositions and means for the treatment of burns and other cutaneous traumas
12/03/1998WO1998053848A1 PHARMACEUTICAL PREPARATION COMPRISING vWF PROPEPTIDE
12/03/1998WO1998053847A1 Transdermal delivery system
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053845A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
12/03/1998WO1998053844A1 Pharmaceutical compostions of peptides having low solubility in physiological medium
12/03/1998WO1998053842A1 Tumor necrosis factor receptor-derived peptide analogues
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053839A2 Anti-cancer products for treating cystic fibrosis
12/03/1998WO1998053838A2 A soluble laminin receptor precursor and methods to inhibit its interactions
12/03/1998WO1998053837A1 COMPOSITIONS SUITABLE FOR CONTROLLED RELEASE OF THE HORMONE GnRH AND ITS ANALOGS
12/03/1998WO1998053830A1 METHODS AND REAGENTS FOR MODULATING TGF-β SUPERFAMILY SIGNALING
12/03/1998WO1998053827A1 Treatment of osteoporosis
1 ... 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 ... 3163